#32026B002452026 mali yılı için gelir ve gider beyanı – Avrupa İlaç Ajansı (EMA)
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
🇬🇧 English
The law outlines the expected income and expenses for the European Medicines Agency (EMA) for the financial year 2026. It affects the EMA and stakeholders in the pharmaceutical industry, as it provides a framework for budgeting and financial planning. This ensures that the agency can effectively manage its resources to support public health initiatives.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Establishment of a budget framework for 2026
- Allocation of funds to specific health initiatives
- Increased transparency in financial reporting
+ 1 more changes with Pro
Affected Parties
European Medicines AgencyPharmaceutical companies+1 more…
Tags
budget,healthcare,pharmaceuticals…